In support of previous data, in the present study, significant prediction of PPARγ suppression as well as decrease in protein expression of numerous mitochondrial enzymes involved in PPARα-controlled β-oxidation of fatty acids was found for NASH-associated HCCs. Here, PPARG is linked to metabolic dysfunction-associated steatohepatitis.